Pasithea Therapeutics Corp. (KTTA) Stock Inclining in After Market. Here’s What you Should Know
Pasithea Therapeutics Corp. (KTTA) is one of the leading biopharmaceutical companies mainly engaged in the development and research of therapies related to psychiatry and neurological